EC Number | Application | Comment | Organism |
---|---|---|---|
3.4.11.16 | medicine | chemotherapeutic target, involved in heart disease, metastasis, inflammation | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.11.16 | amastatin | 50% inhibition at 0.00158 mM | Sus scrofa | |
3.4.11.16 | bestatin | - |
Homo sapiens | |
3.4.11.16 | bestatin | 50% inhibition at 0.0079 mM | Sus scrofa | |
3.4.11.16 | additional information | overlap of inhibitory effects of typical aminopeptidase inhibitors with other enzymes | Sus scrofa | |
3.4.11.16 | probestin | 50% inhibition at 0.005 mM | Sus scrofa | |
3.4.11.16 | rentiapril | 50% inhibition at 0.0016 mM | Sus scrofa | |
3.4.11.16 | zofenoprilat | 50% inhibition at 0.018 mM | Sus scrofa |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.11.16 | Homo sapiens | - |
- |
- |
3.4.11.16 | Sus scrofa | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.4.11.16 | peripheral nervous system | - |
Homo sapiens | - |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
3.4.11.16 | 37 | - |
assay at | Homo sapiens |
3.4.11.16 | 37 | - |
assay at | Sus scrofa |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
3.4.11.16 | 7.4 | - |
assay at | Sus scrofa |